Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Acquisitions | $16,629 | 1 | 47.5% |
| Current or prospective ownership or investment interest | $11,986 | 6 | 34.2% |
| Food and Beverage | $5,444 | 136 | 15.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $830.90 | 2 | 2.4% |
| Honoraria | $136.00 | 4 | 0.4% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US Retina LLC | $28,615 | 13 | $0 (2022) |
| Genentech USA, Inc. | $1,760 | 67 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,486 | 23 | $0 (2024) |
| Astellas Pharma US Inc | $1,118 | 6 | $0 (2024) |
| Alcon Vision LLC | $392.84 | 3 | $0 (2022) |
| Alcon Laboratories Inc | $233.93 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $219.07 | 5 | $0 (2019) |
| NotalVision | $206.66 | 8 | $0 (2019) |
| Allergan, Inc. | $198.68 | 15 | $0 (2020) |
| Regeneron Pharmaceuticals, Inc. | $139.59 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,696 | 22 | Astellas Pharma US Inc ($1,030) |
| 2023 | $898.53 | 17 | Genentech USA, Inc. ($369.54) |
| 2022 | $21,696 | 17 | US Retina LLC ($21,276) |
| 2021 | $4,434 | 15 | US Retina LLC ($4,000) |
| 2020 | $1,652 | 8 | US Retina LLC ($1,445) |
| 2019 | $2,712 | 26 | US Retina LLC ($1,895) |
| 2018 | $680.17 | 16 | Genentech USA, Inc. ($339.13) |
| 2017 | $1,257 | 34 | Genentech USA, Inc. ($527.63) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/11/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: EYE CARE | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/05/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: OPTOMETRY | ||||||
| 10/22/2024 | Notal Vision, Inc. | Foresee Home (Device) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Ophthalmology | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $38.32 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/17/2024 | Astellas Pharma US Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| 08/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $36.98 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/10/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/30/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 04/29/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Ophthalmology | ||||||
| 04/03/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 03/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $123.41 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $39.51 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $35.22 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/05/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: EYE CARE | ||||||
| 01/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $111.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/08/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/04/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $55.00 | General |
| 10/24/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $148.76 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,899 | 10,953 | $5.3M | $1.9M |
| 2022 | 12 | 1,855 | 7,710 | $4.5M | $2.0M |
| 2021 | 14 | 1,874 | 7,876 | $4.5M | $2.0M |
| 2020 | 13 | 2,012 | 8,461 | $4.7M | $2.2M |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 128 | 1,432 | $1.8M | $984,978 | 55.0% |
| J3590 | Unclassified biologics | Office | 2023 | 66 | 93 | $1.1M | $250,129 | 23.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 42 | 1,177 | $588,500 | $216,044 | 36.7% |
| J3490 | Unclassified drugs | Office | 2023 | 25 | 74 | $520,500 | $145,112 | 27.9% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 11 | 4,620 | $196,350 | $134,682 | 68.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 220 | 1,121 | $756,675 | $100,823 | 13.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 394 | 547 | $95,725 | $32,325 | 33.8% |
| 92134 | Imaging of retina | Office | 2023 | 260 | 887 | $88,700 | $24,928 | 28.1% |
| 92250 | Photography of the retina | Office | 2023 | 479 | 635 | $95,250 | $15,829 | 16.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 96 | 100 | $25,000 | $9,787 | 39.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 31 | 116 | $11,600 | $6,404 | 55.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 80 | 80 | $17,200 | $5,999 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $8,820 | $3,109 | 35.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 31 | $3,565 | $1,265 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $3,000 | $918.12 | 30.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 121 | 1,800 | $2.3M | $1.3M | 57.1% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 64 | 2,028 | $1.0M | $451,381 | 44.5% |
| 67028 | Injection of drug into eye | Office | 2022 | 221 | 1,228 | $828,900 | $110,692 | 13.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 376 | 525 | $88,475 | $31,569 | 35.7% |
| 92134 | Imaging of retina | Office | 2022 | 262 | 1,010 | $101,000 | $29,353 | 29.1% |
| 92250 | Photography of the retina | Office | 2022 | 495 | 650 | $97,500 | $16,517 | 16.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 86 | 86 | $26,370 | $9,328 | 35.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 37 | 169 | $16,900 | $8,695 | 51.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 97 | 102 | $25,500 | $8,624 | 33.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 43 | 43 | $9,125 | $3,456 | 37.9% |
About Dr. Raynor Casey, M.D
Dr. Raynor Casey, M.D is a Ophthalmology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821014440.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raynor Casey, M.D has received a total of $35,026 in payments from pharmaceutical and medical device companies, with $1,696 received in 2024. These payments were reported across 155 transactions from 19 companies. The most common payment nature is "Acquisitions" ($16,629).
As a Medicare-enrolled provider, Casey has provided services to 7,640 Medicare beneficiaries, totaling 35,000 services with total Medicare billing of $8.1M. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Raleigh, NC
- Active Since 07/15/2006
- Last Updated 09/24/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1821014440
Products in Payments
- Lucentis (Biological) $1,232
- EYLEA (Biological) $654.49
- EYLEA HD (Biological) $541.98
- Vabysmo (Drug) $432.16
- EYLEA AFLIBERCEPT INJECTION (Biological) $429.02
- OZURDEX (Drug) $274.81
- Izervay (Drug) $229.69
- ForeseeHome (Device) $206.66
- NGENUITY (Device) $149.10
- AcrySof IQ VIVITY IOL (Device) $129.71
- Syfovre (Drug) $122.07
- CyPass (Device) $121.84
- Clareon (Device) $114.03
- ACTIVEFOCUS (Device) $112.09
- VYZULTA (Drug) $101.24
- Bromsite (Drug) $100.00
- BEOVU (Drug) $89.28
- VABYSMO (Drug) $67.57
- IHEEZO (Drug) $24.02
- SUSVIMO (Drug) $18.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Raleigh
Preeya Gupta, Md, MD
Ophthalmology — Payments: $1.7M
Dr. Daniel Bennett, Md, MD
Ophthalmology — Payments: $149,562
Sachin Mudvari, Md, MD
Ophthalmology — Payments: $33,257
John Thordsen, Md, MD
Ophthalmology — Payments: $31,927
Isaac Porter, M.d, M.D
Ophthalmology — Payments: $9,542
Dr. Nitin Gupta, M.d., M.p.h, M.D., M.P.H
Ophthalmology — Payments: $8,730